title: Could the combination of celecoxib and 4HPR be an effective lung cancer treatment?
authors.affiliation: Department of Pathology, Arizona Cancer Center, The University of Arizona College of Medicine, Tucson, USA.
authors.forename: Durga P
authors.initials: DP
authors.lastname: Cherukuri
authors.forename: Mark A
authors.initials: MA
authors.lastname: Nelson
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000068579:Celecoxib; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage; D017313:Fenretinide / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D011720:Pyrazoles / Q000008:administration & dosage; D013449:Sulfonamides / Q000008:administration & dosage
chemical_list: D000970:Antineoplastic Agents; D052246:Cyclooxygenase 2 Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D017313:Fenretinide; D000068579:Celecoxib